Several studies have demonstrated that ICAM-1 is upregulated during inflammation, asthma, rheumatoid arthritis and lung injury (33–36), and the expression of ICAM-1 is mediated by various inflammatory cytokines, particularly TNF-α (37). This evidence concerns the gene TNF and asthma.